Michael H Schiff, MD
Michael Schiff, MD, is currently a Clinical Professor of Medicine in the Rheumatology Division at the University of Colorado School of Medicine in Denver. Dr Schiff received his undergraduate training at the University of Chicago. He completed his medical degree at the State University of New York (SUNY) Downstate Medical Center. Dr Schiff completed his Internal Medicine residency at Albany Medical Center, Hospital of Union University School of Medicine and a fellowship in Rheumatology at SUNY Downstate Medical Center. Board certified in Internal Medicine and Rheumatology, Dr Schiff founded the Denver Arthritis Clinic and served as a Rheumatologist and Medical Director of the clinic’s Research Unit from 1976-2008.
He has received a number of Outstanding Clinical Faculty awards from the University of Colorado School of Medicine, including the Academic Publications Award, Career Achievement Award, and the Research Project Award. A principal investigator for more than 200 research projects, Dr Schiff has published 50 peer-reviewed journal articles and 300 scientific abstracts.
Dr Schiff is a Master of the American College of Rheumatology, as well as a member of numerous regional and national medical societies. In addition, Dr Schiff has served as a board member of the American College of Rheumatology Research Education Foundation and was Vice President of the foundation from 2001 to 2002. A two-term president of the Colorado Society of Internal Medicine, Dr Schiff’s primary interest has been in the use of DMARDS (disease-modifying antirheumatic drugs) and biologics for management of rheumatoid arthritis.
Consultancy – AbbVie, BMS, Eli Lilly, Janssen, UCB; Speaker bureau – AbbVie